
You are here
Database of TGA laboratory testing results
Important information on the Database of TGA Laboratory testing results
Safety alerts
When we identify serious safety or quality issues with therapeutic goods, information and recommendations are posted immediately on the Safety information pages of the TGA website.
This database does NOT provide timely alerts to healthcare professionals and consumers where a serious safety or quality issue has been identified.
About the TGA Laboratory testing results
Limitations of test results
Sponsors
Unregistered therapeutic goods
About the release of this information
While reasonable care is taken to ensure that the information is an accurate record of the results and outcomes of TGA's laboratory testing, the TGA does not guarantee or warrant the accuracy, reliability, completeness or currency of the information or its usefulness in achieving any purpose.
To the fullest extent permitted by law, including but not limited to section 61A of the Therapeutic Goods Act 1989, the TGA will not be liable for any loss, damage, cost or expense incurred in or arising by reason of any person relying on this information.
Test results
Displaying 41 - 50 of 3484
ACTILYSE alteplase (rch) 50 mg powder for injection vial with diluent vial
Testing category: Programmed
Product type: Prescription Medicines
ARTG ID: 17905
Sponsor: Boehringer Ingelheim Pty Ltd
Reason for testing: Survey of a Medicine/Device Group
Result: PASS
Sample number: 1904001510
Batch number: 903710
Expiry date: 31-Dec-2021
Active Organics Absolute Control capsules
Testing category: Unregistered
Product type: Unregistered
ARTG ID: N/A
Sponsor: N/A
Reason for testing: Regulatory Investigation & Enforcement Testing
Result: FAIL: Prohibited Substance Detected
Outcome: Goods declared as Prohibited Import and destroyed.
ACTRAPID PENFILL human insulin (rys) 100IU/mL injection multidose cartridge
Testing category: Programmed
Product type: Prescription Medicines
ARTG ID: 169623
Sponsor: Novo Nordisk Pharmaceuticals Pty Ltd
Reason for testing: Survey of a Medicine/Device Group
Result: PASS
ACYCLO-V 200 Aciclovir 200mg tablet blister pack
Testing category: Programmed
Product type: Prescription Medicines
ARTG ID: 56372
Sponsor: Alphapharm Pty Ltd
Reason for testing: Survey of a Medicine/Device Group
Result: PASS
ADACEL pertussis vaccine-acellular combined with diphtheria and tetanus toxoids (adsorbed) 0.5mL injection vial
Testing category: Batch release evaluation
Product type: Prescription Medicines
ARTG ID: 106554
Sponsor: Sanofi-Aventis Australia Pty Ltd
Reason for testing: Batch Release
Result: PASS
ADACEL pertussis vaccine-acellular combined with diphtheria and tetanus toxoids (adsorbed) 0.5mL injection vial
Testing category: Batch release evaluation
Product type: Prescription Medicines
ARTG ID: 106554
Sponsor: Sanofi-Aventis Australia Pty Ltd
Reason for testing: Batch Release
Result: PASS
Sample number: 2002000604
Batch number: C5686AC
Expiry date: 31-Jan-2022
ADACEL pertussis vaccine-acellular combined with diphtheria and tetanus toxoids (adsorbed) 0.5mL injection vial
Testing category: Batch release evaluation
Product type: Prescription Medicines
ARTG ID: 106554
Sponsor: Sanofi-Aventis Australia Pty Ltd
Reason for testing: Batch Release
Result: PASS
Sample number: 2002000602
Batch number: C5686AB
Expiry date: 31-Jan-2022
ADACEL pertussis vaccine-acellular combined with diphtheria and tetanus toxoids (adsorbed) 0.5mL injection vial
Testing category: Batch release evaluation
Product type: Prescription Medicines
ARTG ID: 106554
Sponsor: Sanofi-Aventis Australia Pty Ltd
Reason for testing: Batch Release
Result: PASS
Sample number: 2002000603
Batch number: C5686AB
Expiry date: 31-Jan-2022
ADACEL pertussis vaccine-acellular combined with diphtheria and tetanus toxoids (adsorbed) 0.5mL injection vial
Testing category: Batch release testing
Product type: Prescription Medicines
ARTG ID: 106554
Sponsor: Sanofi-Aventis Australia Pty Ltd
Reason for testing: Batch Release
Result: PASS
Sample number: 1901000184
Batch number: C5489AB
Expiry date: 31-Jan-2021
ADACEL pertussis vaccine-acellular combined with diphtheria and tetanus toxoids (adsorbed) 0.5mL injection vial
Testing category: Batch release evaluation
Product type: Prescription Medicines
ARTG ID: 106554
Sponsor: Sanofi-Aventis Australia Pty Ltd
Reason for testing: Batch Release
Result: PASS